Westover Capital Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1483467 WILMINGTON, DE

Position in GILD

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$2,006,910

-$260,918 QoQ

Shares Held

15,885

-2.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#833

of 2,266 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Westover Capital Advisors, LLC holds $13,813,106 across 9 Drug Manufacturers - General names. GILD ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,728	$4,471,475
2	ABBV	AbbVie Inc.	8,549	$2,151,270
3	GILD	Gilead Sciences, Inc. This page	15,885	$2,006,910
4	JNJ	Johnson & Johnson	6,016	$1,527,883
5	MRK	Merck & Co., Inc.	11,716	$1,505,506
6	AMGN	Amgen Inc	2,375	$860,035
7	AZN	Astrazeneca PLC	4,458	$845,325
8	BMY	Bristol Myers Squibb Co	4,182	$240,966

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,006,910	15,885	-2.4%	Shares	Sole	2026-08-04
2026-03-31	$2,267,828	16,272	+8.6%	Shares	Sole	2026-05-05
2025-12-31	$1,838,522	14,979	-2.1%	Shares	Sole	2026-02-09
2025-09-30	$1,698,744	15,304	+1.4%	Shares	Sole	2025-11-06
2025-06-30	$1,672,584	15,086	+119.1%	Shares	Sole	2025-08-11
2025-03-31	$771,688	6,887	+82.2%	Shares	Sole	2025-05-06
2023-12-31	$306,136	3,779	+0.5%	Shares	Sole	2024-02-06
2023-09-30	$281,774	3,760	0.0%	Shares	Sole	2023-11-13
2023-06-30	$289,783	3,760	-51.2%	Shares	Sole	2023-08-11
2020-09-30	$486,499	7,699	-18.4%	Shares	Sole	2020-11-19
2020-06-30	$726,236	9,439	+179.8%	Shares	Sole	2020-08-14
2020-03-31	$252,165	3,373	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.